You have /5 articles left.
Sign up for a free account or log in.
The U.S. Supreme Court on Monday ruled 7-2 that a pharmaceutical company did not infringe a Stanford University patent on a technology that measures the concentration of HIV in blood plasma -- a result that higher education groups have warned would undercut the federal government's 30-year-old system for determining who owns the rights to inventions created using federal funds. The court's ruling came in a case known as Stanford v. Roche. Coverage to follow on Inside Higher Ed tomorrow.
Want articles like this sent straight to your inbox?
Subscribe to a Newsletter
